# Methylene Blue for the Treatment of Septic Shock

> **NCT06532240** · PHASE3 · COMPLETED · sponsor: **Northern Jiangsu People's Hospital** · enrollment: 88 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Methylene Blue
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06532240
- **Lead sponsor:** Northern Jiangsu People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-05
- **Primary completion:** 2025-10-24
- **Final completion:** 2025-10-24
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06532240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06532240, "Methylene Blue for the Treatment of Septic Shock". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06532240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*